Organoid Analysis Platform
Oncology (Pancreatic Cancer validated)
Development/ValidationActive
Key Facts
Indication
Oncology (Pancreatic Cancer validated)
Phase
Development/Validation
Status
Active
Company
About Orbits Oncology
Orbits Oncology is a private, pre-revenue biotech platform company founded in 2019 and incorporated in the USA in 2023. The company has developed a device-agnostic, AI-powered digital platform that analyzes images of patient-derived tumor organoids to provide actionable insights for drug discovery and clinical research. Its core value proposition is automating the analysis of living tumor models to identify treatment-resistant subclones and predict patient outcomes, thereby aiming to improve clinical trial stratification and personalized treatment strategies. The company is currently building a waitlist for its platform and has published collaborative research in npj Precision Oncology.
View full company profile